Whole-body MR neurography: Prospective feasibility study in polyneuropathy and Charcot-Marie-Tooth disease

Purpose To evaluate the feasibility of whole‐body magnetic resonance neurography (WBMRN) in polyneuropathy for technical feasibility, distribution of nerve abnormalities, and differentiation. Materials and Methods Twenty WBMRN examinations were performed on a 3T scanner over 2 years. Patient demogra...

Full description

Saved in:
Bibliographic Details
Published inJournal of magnetic resonance imaging Vol. 44; no. 6; pp. 1513 - 1521
Main Authors Chhabra, Avneesh, Carrino, John A., Farahani, Sahar J., Thawait, Gaurav K., Sumner, Charlotte J., Wadhwa, Vibhor, Chaudhary, Vinay, Lloyd, Thomas E.
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.12.2016
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Purpose To evaluate the feasibility of whole‐body magnetic resonance neurography (WBMRN) in polyneuropathy for technical feasibility, distribution of nerve abnormalities, and differentiation. Materials and Methods Twenty WBMRN examinations were performed on a 3T scanner over 2 years. Patient demographics including history of hereditary and acquired neuropathy were recorded. The images were evaluated by two independent readers with nerve imaging experience for quality. The nerve signal and size alterations were measured in the brachial plexus, lumbosacral plexus, and femoral and sciatic nerves; diffusion tensor imaging parameters (fractional anisotropy [FA] and apparent diffusion coefficient [ADC]) were determined in plexuses, and tractography was performed. Nonparametric Wilcoxon rank sum test, receiver operating characteristic (ROC) analysis, and intraclass correlation coefficients (ICCs) were obtained. Results Excellent image quality was obtained for the majority of lumbosacral (LS) plexus (18/20) and 50% of brachial plexus (10/20) regions. Qualitatively among cases, the nerve hyperintensity and/or thickening involved the brachial plexus (11/11), LS plexus (7/11), and both plexuses (7/11), with most nerve thickenings observed in Charcot‐Marie‐Tooth disease type 1. The nerve signal intensity alterations were significantly different for both brachial (P < 0.05) and LS (P < 0.05) plexuses in cases versus controls. The femoral and sciatic nerve size alterations were different (P < 0.05), while signal intensity differences were not significant (P = 0.1–0.97). Transverse dimensions of C8 (4 mm), L5 (6.2 mm) and S1 (5.1 mm) nerve roots, and sciatic nerves (10.2 mm) were the most accurate diagnostic performance measures in distinguishing cases from controls. Conclusion WBMRN is feasible for use in the clinical practice for the identification and potential characterization of polyneuropathy. J. Magn. Reson. Imaging 2016;44:1513–1521.
Bibliography:ArticleID:JMRI25293
istex:EEABA424707C6657315236309D2DA17EFB9873A3
ark:/67375/WNG-DRNK0WDN-6
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1053-1807
1522-2586
DOI:10.1002/jmri.25293